18β-Glycyrrhetinic Acid, a Novel Naturally Derived Agent, Suppresses Prolactin Hyperactivity and Reduces Antipsychotic-Induced Hyperprolactinemia in In Vitro and In Vivo Models.

This study provides additional evidence in support of GA as an adjunct for the treatment of hyperPRL. PMID: 27161375 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27161375?dopt=Abstract

Source: Neurochemical Research - May 8, 2016 Category: Neuroscience Authors: Wang D, Zhang Y, Wang C, Jia D, Cai G, Lu J, Wang D, Zhang ZJ Tags: Neurochem Res Source Type: research